Aligos Therapeutics Inc (ALGS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ALGS? Forum Prognose

Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	77.19% 0.169	0.741	0.965	0.311	0.606
Operating Expenses	24.46% 21.98	29.10	19.53	19.55	21.19
Benefits Costs and Expenses	37.87% 20.02	32.22	16.64	-42.82	82.73
Costs And Expenses	37.87% 20.02	32.22	16.64	-42.82	82.73
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	23.08% -21.81	-28.36	-18.57	-19.24	-20.56
Net Interest Income/Expense	50.00% 0.60	0.40	0.40	0.80	0.30
Interest Income/Expense After Provision For Losses	50.00% 0.60	0.40	0.40	0.80	0.30
Income/Loss From Continuing Operations Before Tax	36.94% -19.85	-31.48	-15.68	43.13	-82.12
Income Tax Expense/Benefit	46.43% 0.03	0.056	0.185	0.043	0.027
Income/Loss From Continuing Operations After Tax	36.96% -19.88	-31.54	-15.86	43.09	-82.15
Net Income/Loss	36.96% -19.88	-31.54	-15.86	43.09	-82.15
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.38% 0.1681	10.37	10.35	8.4085	0.00591
Diluted Average Shares	98.38% 0.1681	10.37	10.35	8.7097	0.00591
Basic Earnings Per Share	33.88% -2.01	-3.04	-1.53	5.12	-13.10
Diluted Earnings Per Share	33.88% -2.01	-3.04	-1.53	-2.11	-13.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%